Biobanking multifocal breast carcinomas: Sample adequacy with regard to histology and DNA content

Histopathology

Volumn 68, Issue 3, 2016, Pages 411-421

  Pekar, Gyula ^a   Davies, Hanna ^b   Lukacs, Agnes P ^a   Forsberg, Lars ^b   Hellberg, Dan ^b   Dumanski, Jan ^b   Tot, Tibor ^a  

^a FALUN HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Biobanking; Breast cancer; DNA quality and quantity; Heterogeneity; Multifocality

Indexed keywords

ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CONTROLLED STUDY; DNA CONTENT; DNA ISOLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CANCER; PRIORITY JOURNAL; PUNCH BIOPSY; TUMOR VOLUME; BIOBANK; BIOPSY; BREAST TUMOR; CARCINOMA; FEMALE; HISTOLOGY; PATHOLOGY; STANDARDS;

DNA;

BIOLOGICAL SPECIMEN BANKS; BIOPSY; BREAST NEOPLASMS; CARCINOMA; DNA, NEOPLASM; FEMALE; HISTOLOGICAL TECHNIQUES; HUMANS;

EID: 84953839491     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12758     Document Type: Article

References (36)

1. Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 2001; 98; 10869-10874.
2. Pekar G, Hofmeyer S, Tabár L et al. Multifocal breast cancer documented in large-format histology sections: long-term follow-up results by molecular phenotypes. Cancer 2013; 119; 1132-1139.
3. Goldhirsch A, Winer EP, Coates AS et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann. Oncol. 2013; 24; 2206-2223.
4. Tot T, Gere M, Pekár G et al. Breast cancer multifocality, disease extent, and survival. Hum. Pathol. 2011; 42; 1761-1769.
5. Tot T. Axillary lymph node status in unifocal, multifocal, and diffuse breast carcinomas: differences are related to macrometastatic disease. Ann. Surg. Oncol. 2012; 19; 3395-3401.
6. Weissenbacher TM, Zschage M, Janni W et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res. Treat. 2010; 122; 27-34.
7. Boyages J, Jayasinghe UW, Coombs N. Multifocal breast cancer and survival: each focus does matter particularly for larger tumours. Eur. J. Cancer 2010; 46; 1990-1996.
8. Boros M, Ilyes A, Nechifor Boila A et al. Morphologic and molecular subtype status of individual tumor foci in multiple breast carcinoma. A study of 155 cases with analysis of 463 tumor foci. Hum. Pathol. 2014; 45; 409-416.
9. Polyak K. Heterogeneity in breast cancer. J. Clin. Invest. 2011; 121; 3786-3788.
10. Bertos NR, Park M. Breast cancer-one term, many entities? J. Clin. Invest. 2011; 121; 3789-3796.
11. Pekar G, Gere M, Tarjan M et al. Molecular phenotype of the foci in multifocal invasive breast carcinomas: intertumoral heterogeneity is related to shorter survival and may influence the choice of therapy. Cancer 2014; 120; 26-34.
12. Diaz Z, Aguilar-Mahecha A, Paquet ER et al. Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine. Mod. Pathol. 2013; 26; 1413-1424.
13. Tot T. The role of large-format histopathology in assessing subgross morphological prognostic parameters: a single institution report of 1000 consecutive breast cancer cases. Int. J. Breast Cancer 2012; 2012; 395-415.
14. Tot T. The origins of early breast carcinoma. Semin. Diagn. Pathol. 2010; 27; 62-68.
15. Tot T. Subgross morphology, the sick lobe hypothesis, and the success of breast conservation. Int. J. Breast Cancer 2011; 2011; 1-8.
16. Kahan Z, Tot T. Breast cancer, a heterogeneous disease entity. The very early stages. In Tot T ed. Large-format histology, a prerequisite for adequate assessment of early breast carcinomas. Berlin: Springer, 2011; 57-88.
17. Yildiz-Aktas IZ, Dabbs DJ, Bhargava R. The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma. Mod. Pathol. 2012; 25; 1098-1105.
18. http://www.illumina.com/documents/products/datasheets/datasheet_CytoSNP850K_POP.pdf
19. Tot T, Tabár L, Dean PB. Practical breast pathology. 2nd ed. Stuttgart: Thieme, 2014.
20. Tot T. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histological sections. Cancer 2007; 7; 581-587.
21. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ eds. World Health Organization classification of tumours of the breast. 4th ed. Lyon: IARC Press, 2012.
22. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19; 403-410.
23. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 2002; 41; 154-161.
24. Gerlinger M, Rowan AJ, Horswell S et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 2012; 366; 883-892.
25. Li Z, Moore DH, Meng ZH et al. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients. Cancer Res. 2002; 62; 1000-1003.
26. Majidzadeh AK, Kaviani A, Esmaeili R et al. Iranian Breast Cancer Bio-Bank: the activity and challenging issues. Cell Tissue Bank 2013; 14; 11-20.
27. Cole KA, Krizman DB, Emmert-Buck MR. The genetics of cancer-a 3D model. Nat. Genet. 1999; 21(Suppl. 1); 38-41.
28. Edge S, Byrd DR, Compton CC et al. AJCC cancer staging handbook. 7th ed. New York: Springer, 2010.
29. Mee BC, Carroll P, Donatello S et al. Maintaining breast cancer specimen integrity and individual or simultaneous extraction of quality DNA, RNA, and proteins from Allprotect-stabilized and nonstabilized tissue samples. Biopreserv. Biobank. 2011; 9; 389-398.
30. Bonin S, Stanta G. Nucleic acid extraction methods from fixed and paraffin-embedded tissues in cancer diagnostics. Expert Rev. Mol. Diagn. 2013; 13; 271-282.
31. Thyagarajan B, Anderson KE, Kong F et al. New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study. J. Clin. Pathol. 2005; 58; 955-961.
32. Do H, Dobrovic A. Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization. Clin. Chem. 2015; 61; 64-71.
33. http://medicine.yale.edu/keck/ycga/services/samples/genomic.aspx
34. Yu L, Yang W, Cai X et al. Centrally necrotizing carcinoma of the breast: clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis. Histopathology 2010; 57; 193-201.
35. Hammond ME, Hayes DF, Dowsett M et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen progesterone receptors in breast cancer. Arch. Pathol. Lab. Med. 2010; 134; e48-e72.
36. Neumeister VM, Anagnostou V, Siddiqui S et al. Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. J. Natl Cancer Inst. 2012; 104; 1815-1824.